Clinical trial
Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic…
NCT00107770 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00107770 |
|---|---|
| Title | Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis) |
| Official title | Safety and Dose Escalating Study of Oral Sodium Phenylbutyrate in Subjects With Amyotrophic Lateral Sclerosis |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Muscular Dystrophy Association |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis |
| Intervention type | Drug |
| Interventions | sodium phenylbutyrate |
| Enrollment | 40 |
| Start date | Apr 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Apr 8, 2005 |
| Last update posted | Jan 11, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: